Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling

Author:

Watzky Manon1,Huard Solène1,Juricek Ludmila2,Dairou Julien34,Chauvet Caroline23,Coumoul Xavier23,Letessier Anne1,Miotto Benoit1ORCID

Affiliation:

1. Université Paris Cité, Institut Cochin , INSERM, U1016, CNRS, UMR8104, F-75014 Paris, France

2. METATOX, T3S, Toxicologie Environnementale, Cibles thérapeutiques, Signalisation cellulaire et Biomarqueurs , INSERM UMR-S1124, F-75006 Paris, France

3. Université Paris Cité, UFR des Sciences Fondamentales et Biomédicales , Paris, France

4. Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques , CNRS, UMR 8601, Université Paris Cité, F-75006 Paris, France

Abstract

Abstract The aryl hydrocarbon receptor (AHR) regulates the expression of numerous genes in response to activation by agonists including xenobiotics. Although it is well appreciated that environmental signals and cell intrinsic features may modulate this transcriptional response, how it is mechanistically achieved remains poorly understood. We show that hexokinase 2 (HK2) a metabolic enzyme fuelling cancer cell growth, is a transcriptional target of AHR as well as a modulator of its activity. Expression of HK2 is positively regulated by AHR upon exposure to agonists both in human cells and in mice lung tissues. Conversely, over-expression of HK2 regulates the abundance of many proteins involved in the regulation of AHR signalling and these changes are linked with altered AHR expression levels and transcriptional activity. HK2 expression also shows a negative correlation with AHR promoter methylation in tumours, and these tumours with high HK2 expression and low AHR methylation are associated with a worse overall survival in patients. In sum, our study provides novel insights into how AHR signalling is regulated which may help our understanding of the context-specific effects of this pathway and may have implications in cancer.

Funder

Labex

Fondation pour la Recherche Medicale

Inserm

CNRS

University Paris Cité

INCa-Plan Cancer

Groupement des Entreprises Ile-de-France contre le cancer

Ligue Régionale Contre le Cancer Ile-de-France

Publisher

Oxford University Press (OUP)

Subject

Genetics

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3